Recursion jumps after solid Q4 beat

2026-02-25 11:42:41 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript Recursion Pharmaceuticals: Stock Unresponsive To Clinical Updates Recursion Pharmaceuticals, Inc. (RXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Recursion Pharmaceuticals GAAP EPS of -$0.21 beats by $0.08, revenue of $35.54M beats by $10.98M Recursion Pharmaceuticals Q4 2025 Earnings Preview Read the full article on Seeking Alpha For further details see: Recursion jumps after solid Q4 beat